Page 362 - Multidisipliner Covid 19
P. 362
BÖLÜM 22
19. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill
patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-cen-
tered, retrospective, observational study. Lancet Respir Med. Lancet
Respir Med. 2020;8(5):475-481.
20. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized
patients with 2019 novel coronavirus–infected pneumonia in Wuhan,
China. JAMA. 2020; 323(11):1061-1069.
21. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteris-
tics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:
a descriptive study. Lancet. 2020;395(10223):507-513.
22. Asadi-Pooya AA, Simani L. Central nervous system manifestations of
COVID-19: A systematic review. J Neurol Sci. 2020;15;413:116832.
23. Tunç A, Ünlübaş Y, Alemdar M, Akyüz E. Coexistence of COVID-19
and acute ischemic stroke report of four cases. J Clin Neurosci. 2020;
S0967-5868(20)31081-X.
24. Valderrama EV, Humbert K, Humbert A, Frontera J, Yaghi S. Severe
Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic
Stroke. 2020;51: STROKEAHA.120.030153.
25. Rodríguez-Pardo J, Fuentes B, Alonso de Leciñana M et al. Acute stroke
care during the COVID-19 pandemic. Ictus Madrid Program recommen-
dations. Neurología. 2020;35(4):258-263.
26. Smith MS, Bonomo J, Knight WA, et al. Endovascular Therapy for
Patients With Acute Ischemic Stroke During the COVID-19 Pandemic
A Proposed Algorithm. Stroke. 2020; 51(6):1902-1909.
27. Ong JJY, Bharatendu C, Goh Y, et al. Headaches associated with personal
protective equipment – A cross-sectional study smong frontline health-
care workers during COVID-19. Headache. 2020;60(5):864-877.
28. Szperka CL, Ailani J, Barmherzig R, et al. Migraine care in the era of
COVID-19: Clinical pearls and plea to insurers. Headache. 2020;60(5):-
833-842.
29. Bolay H, Gül A, Balkan B. COVID-19 is a Real Headache. Headache.
2020; May 15:10.1111/head.1385.
30. Tfelt-Hansen P, Loder E. The emperor’s new gepants: Are the effects
of the new oral CGRP antagonists clinically meaningful? Headache.
2019;59(1):113–117.
31. Wells RE, Strauss LD. The Value of Headache-Specific Recommendations
During COVID-19. Headache. 2020;60(5):820-823.
361